Impact of COVID-19 surgical delays on chronic venous disease: a multicenter observational study in France

IntroductionCOVID-19 lockdowns led to widespread postponement of elective procedures, including endovenous interventions for chronic venous disease (CVD). This study aimed to evaluate the clinical impact of delayed thermal ablation in a real-world French multicenter cohort.MethodsThis prospective, multicenter observational study included 203 adults with documented great or small saphenous vein insufficiency or recurrent varicose veins whose endovenous procedures were postponed during the 2020-2021 lockdowns. Clinical severity was assessed using the Venous Clinical Severity Score (VCSS) and CEAP classification at the postponement assessment and at the rescheduling assessment. The primary analysis was performed on patients with a VCSS available at both time points. Paired t-tests and Wilcoxon signed-rank tests were used to assess within-patient change over time.ResultsAmong 203 enrolled patients, 86 (42.4%) had a VCSS available at both time points and were included in the primary analysis. The median delay between the postponement and rescheduling assessments was 80 days (IQR 69-101). Mean VCSS remained unchanged (5.4±3.0 vs 5.4±2.8; mean difference 0.0, 95% CI -0.4 to 0.4). CEAP classification was stable in 89.5% of patients, with no significant overall shift (p = 0.246). Adverse events occurred in 3.5% of cases, mainly superficial vein thrombosis. Physicians reported a negative impact of the delay in 60% of assessments, and a physician-perceived potential loss of therapeutic opportunity in 7.5% of the full cohort (n = 199) and 20.9% of the paired cohort at rescheduling (n = 86).ConclusionIn this real-world cohort, delayed endovenous treatment for CVD was not associated with clinically evident short-term deterioration in this sample. However, the high rate of missing paired data, the resulting risk of selection bias, and limited statistical power mean that a clinically relevant effect cannot be excluded. These findings suggest relative clinical stability in mild-to-moderate CVD during short-term delays, but further adequately powered studies are required.

Authors

Institutions

Publication Details

Journal
Phlebology The Journal of Venous Disease
Published
2026-11-16
DOI
https://doi.org/10.1177/02683555261503893
Primary Topic
Diagnosis and Treatment of Venous Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of COVID-19 surgical delays on chronic venous disease: a multicenter observational study in France

Nicolas Neaume, Matthieu Josnin
1 links
Phlebology The Journal of Venous Disease
Diagnosis and Treatment of Venous Diseases
article

Impact of COVID-19 surgical delays on chronic venous disease: a multicenter observational study in France

Nicolas Neaume, Matthieu Josnin
article en

Abstract

IntroductionCOVID-19 lockdowns led to widespread postponement of elective procedures, including endovenous interventions for chronic venous disease (CVD). This study aimed to evaluate the clinical impact of delayed thermal ablation in a real-world French multicenter cohort.MethodsThis prospective, multicenter observational study included 203 adults with documented great or small saphenous vein insufficiency or recurrent varicose veins whose endovenous procedures were postponed during the 2020-2021 lockdowns. Clinical severity was assessed using the Venous Clinical Severity Score (VCSS) and CEAP classification at the postponement assessment and at the rescheduling assessment. The primary analysis was performed on patients with a VCSS available at both time points. Paired t-tests and Wilcoxon signed-rank tests were used to assess within-patient change over time.ResultsAmong 203 enrolled patients, 86 (42.4%) had a VCSS available at both time points and were included in the primary analysis. The median delay between the postponement and rescheduling assessments was 80 days (IQR 69-101). Mean VCSS remained unchanged (5.4±3.0 vs 5.4±2.8; mean difference 0.0, 95% CI -0.4 to 0.4). CEAP classification was stable in 89.5% of patients, with no significant overall shift (p = 0.246). Adverse events occurred in 3.5% of cases, mainly superficial vein thrombosis. Physicians reported a negative impact of the delay in 60% of assessments, and a physician-perceived potential loss of therapeutic opportunity in 7.5% of the full cohort (n = 199) and 20.9% of the paired cohort at rescheduling (n = 86).ConclusionIn this real-world cohort, delayed endovenous treatment for CVD was not associated with clinically evident short-term deterioration in this sample. However, the high rate of missing paired data, the resulting risk of selection bias, and limited statistical power mean that a clinically relevant effect cannot be excluded. These findings suggest relative clinical stability in mild-to-moderate CVD during short-term delays, but further adequately powered studies are required.

Phlebology The Journal of Venous Disease
Clinique Pasteur (FR)
Société Française de Phlébologie
Good health and well-being
Diagnosis and Treatment of Venous Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon